Hetero is one of India’s leading generic pharmaceutical companies and the world’s largest producer of anti-retroviral drugs for the treatment of HIV/AIDS. Backed by over 25 years of expertise in the pharmaceutical industry, Hetero has 36 state-of-the-art manufacturing facilities strategically located worldwide, audited and approved by stringent regulatory authorities like US FDA, EU, TGA-Australia, MCC-South Africa and others. Hetero Chemical Complex is Asia’s largest manufacturing SEZ Complex for APIs which houses more than 1000 reactors and is spread over 500 acres near Visakhapatnam, India. Their portfolio includes 300 plus products encompassing major therapeutic categories such as HIV/AIDS, Oncology, Cardiovascular, Neurology, Hepatitis, Nephrology, Urology, Diabetes, Ophthalmology, Hepatology, and Immunology, etc. Hetero has a strong global presence in over 126 countries and focusses on making affordable medicines accessible to patients worldwide. Every manufacturing facility is state-of-the-art with integrated quality systems and processes which facilitate absolute compliance with cGMP (current Good Manufacturing Practices). Quality control labs at Hetero are equipped with high-precision equipment which ensures that excellence is maintained consistently throughout the production processes. Also, the highest standards are adhered to when it comes to health, safety, and environmental practices.

Akums Drugs & Pharmaceuticals Ltd., Haridwar, (India), is an internationally recognized WHO-GMP certified and one of the leading contract manufacturing facility which has rapidly emerged as one of the premier integrated pharmaceutical company in India. The organization deals in the manufacturing and export of formulations in a wide spectrum of dosage forms & therapeutic segments. The company is currently supplying to almost all Indian and multinational pharmaceutical companies across the globe. The 9 state-of-the-art facilities of the company are dedicated to oral solid dosage forms (with separate units for beta lactum and non-beta lactum formulations), Oral liquid dosage forms, Sterile dosage forms (Injectable, eye, ear & nasal), hormonal (oral and injectable), Ointments & cosmetics, Ayurvedic, food supplements & nutraceuticals and animal health care. Akums adheres to international standards in their ultra-modern plants to produce world-class formulations in all dosage forms across segments. In a span of few years, the organization has become the icon of Indian Pharmaceutical manufacturing industry and currently manufactures around 9% to 10% of the country’s total medicinal requirements. With creme-de-la-creme of dedicated pharmaceutical personnel and standardized practices, Akums has been successful in attaining national and international accreditations and building trust on Efficacy, Safety & Quality. The organization is certified with WHO-GMP, ISO 9001: 2008, ISO 14001:2004 certificates and various international accreditations, like; ANVISA, Brazil, NAFDAC, Nigeria, FDB, Ghana, PMPB, Malawi amongst others.

DAGON pharma is a fully-integrated Indian Pharmaceutical company manufacturing a wide range of Tablets, Capsules, Oral Liquids, Powders, Injectables, and others. As its vision suggests Dagon is committed to applying the expertise and resources for the improvement of health and well-being of people. It strives to provide access to high quality, effective and affordable health care products to the people across the world. In Dagon, the quality assurance comprises of Corporate QA and Site QA. Site QA is responsible for the implementation of quality systems and the release of all manufactured products. Corporate QA develops and ensures the harmonization of all systems throughout the organization. It is also responsible for all audits including regulatory, customer, GMP, WHO, good laboratory practices and good documentation.

The Madras Pharmaceuticals is one of the most respected contract research and manufacturing (CRAMS) organization in India. Madras Pharmaceuticals are having a B2B business that out licenses the generic products that are developed by in-house R&D to the pharmaceutical marketing companies against a supply agreement. The company started in the year 1979 and at present The Madras Pharma group is a contract manufacturing organization, having 8 manufacturing facilities, 3000 employees, covering all dosage forms and selling products in India and across the world. They are having 7 manufacturing Sites. Two of the facilities (Softgel and Sterilgene) are EU-GMP approved and are going for the USFDA in 2019. The group’s next arm Accent Pharma got a manufacturing facility in Jammu and Pondicherry having the facility to manufacture tablet and capsules. Anphar Organics is another facility under the Madras pharmaceutical group located in Jammu.

Lupin takes pride in its quality-led manufacturing base that keeps the customer at the center of its business philosophy. Lupin’s ability to lead as a global formulations and API powerhouse is an outcome of their unrelenting focus on operational excellence and quality programs. The philosophy is to drive continuous improvement and innovation, facilitate teamwork, eliminate efficiencies and encourage lean manufacturing. They are having 18 manufacturing facilities in India, the United States, Japan, Brazil, and Mexico. As per global manufacturing norms, all pharmaceutical facilities are periodically inspected and audited by regulatory authorities like the US FDA, World Health Organization (WHO), MHRA (UK), TGA (Australia), MHLW (Japan), ANVISA (Brazil) and MCC (South Africa), among others. Lupin's manufacturing facilities are also inspected as a standard practice. This helps to ensure a smooth transfer of inputs into their plants and timely output of products to worldwide customers. The key metrics of deliverance like OTIF (On Time in Full) has remained above 95% in the majority of the markets. This has enabled improvement in metrics like 'Forecast Accuracy', 'Requirement Vs Commitment' and 'Adherence to Plan' in almost any financial year.

Biodeal Pharmaceuticals is extensively engaged in the manufacturing of finished pharmaceutical formulation since 2007 that comply with global standards and strive to achieve market leadership in domestic and international market. The company is boasting of certifications like WHO GMP, ISO 9001:2015, HACCP, FSSAI, GLP, NCB, NCC, SRILANKA-MOH, GEORGIA-MOH. With an emphasis on innovative technologies and high quality standards, they are supposed to be a reliable partner for the pharmaceutical and healthcare industry. The range of services comprises the entire value chain for the development and manufacture of all main dosage forms and product groups for medicines and dietary supplements. More than 200 different formulations of various dosage forms such as Tablets, Capsules, Ointments, Creams/Gel, Lotions, Dusting Powders, Shampoos, Dry Powder Inhalers, Nasal Spray/Drops, Ear Drops, Cosmetics, etc. are currently manufactured in their manufacturing facilities. F&D has a capacity to handle the developmental laboratory trial batches with batch sizes ranging from 500 to 20,000 tablets. F&D has a capability to develop Nasal Spray, Nasal Drops, Ointment, Tablets, Capsules, Powder and Cosmetics. Development Team at R & D centre in Nalagarh (H.P.), supports Biodeal Pharmaceuticals design formulations in its various markets, detailed study and documentation is generated with the help of various country specific registrations for both ROW and Regulated of World Wide Market.